BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18478339)

  • 1. Trends in testicular germ cell cancer incidence in Australia.
    Baade P; Carrière P; Fritschi L
    Cancer Causes Control; 2008 Dec; 19(10):1043-9. PubMed ID: 18478339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996.
    Weir HK; Marrett LD; Moravan V
    CMAJ; 1999 Jan; 160(2):201-5. PubMed ID: 9951441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population based incidence and age distribution of spermatocytic seminoma.
    Carrière P; Baade P; Fritschi L
    J Urol; 2007 Jul; 178(1):125-8. PubMed ID: 17499277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular cancer incidence in eight northern European countries: secular and recent trends.
    Richiardi L; Bellocco R; Adami HO; Torrång A; Barlow L; Hakulinen T; Rahu M; Stengrevics A; Storm H; Tretli S; Kurtinaitis J; Tyczynski JE; Akre O
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2157-66. PubMed ID: 15598775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries.
    Bray F; Richiardi L; Ekbom A; Forman D; Pukkala E; Cuninkova M; Møller H
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):652-8. PubMed ID: 16614105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype-specific incidence of testicular cancer in Germany: a pooled analysis of nine population-based cancer registries.
    Stang A; Rusner C; Eisinger B; Stegmaier C; Kaatsch P
    Int J Androl; 2009 Aug; 32(4):306-16. PubMed ID: 18179558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma?
    Aschim EL; Haugen TB; Tretli S; Daltveit AK; Grotmol T
    Int J Androl; 2006 Aug; 29(4):458-67. PubMed ID: 16487404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular cancer in Luxembourg: incidence and outcome in relation to the different histo-pathological types (1980-2004).
    Scheiden R; Hein T; Wagener C; Kieffer N; Lamy S; Capesius C
    Bull Soc Sci Med Grand Duche Luxemb; 2008; (4):521-39. PubMed ID: 19024372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
    Cooper DE; L'esperance JO; Christman MS; Auge BK
    J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The epidemiology of tumors of the testes in the Netherlands: accurate rendering by the Registry of Histopathology and Cytopathology (PALGA)].
    Post PN; Casparie MK; ten Kate FJ; Oosterhuis JW
    Ned Tijdschr Geneeskd; 2004 Jun; 148(23):1150-4. PubMed ID: 15211966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark.
    Jacobsen R; Møller H; Thoresen SØ; Pukkala E; Kjaer SK; Johansen C
    Int J Androl; 2006 Feb; 29(1):199-204. PubMed ID: 16371112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seminomas of the canine testis. Counterpart of spermatocytic seminoma of men?
    Looijenga LH; Olie RA; van der Gaag I; van Sluijs FJ; Matoska J; Ploem-Zaaijer J; Knepflé C; Oosterhuis JW
    Lab Invest; 1994 Oct; 71(4):490-6. PubMed ID: 7967505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clues to the aetiological heterogeneity of testicular seminomas and non-seminomas: time trends and age-period-cohort effects.
    Liu S; Semenciw R; Waters C; Wen SW; Mery LS; Mao Y
    Int J Epidemiol; 2000 Oct; 29(5):826-31. PubMed ID: 11034964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995.
    McKiernan JM; Goluboff ET; Liberson GL; Golden R; Fisch H
    J Urol; 1999 Aug; 162(2):361-3. PubMed ID: 10411039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frailty modelling of testicular cancer incidence using Scandinavian data.
    Moger TA; Aalen OO; Halvorsen TO; Storm HH; Tretli S
    Biostatistics; 2004 Jan; 5(1):1-14. PubMed ID: 14744824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center.
    Che M; Tamboli P; Ro JY; Park DS; Ro JS; Amato RJ; Ayala AG
    Cancer; 2002 Sep; 95(6):1228-33. PubMed ID: 12216089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpreting the international trends in testicular seminoma and nonseminoma incidence.
    Bray F; Ferlay J; Devesa SS; McGlynn KA; Møller H
    Nat Clin Pract Urol; 2006 Oct; 3(10):532-43. PubMed ID: 17031378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of risk factors for testicular cancer: a hospital-based case-control study in the Czech Republic.
    Dusek L; Abrahamova J; Lakomy R; Vyzula R; Koptikova J; Pavlik T; Muzik J; Klimes D
    Neoplasma; 2008; 55(4):356-68. PubMed ID: 18505349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis.
    Raman JD; Nobert CF; Goldstein M
    J Urol; 2005 Nov; 174(5):1819-22; discussion 1822. PubMed ID: 16217294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testicular cancer.
    Forman D; Møller H
    Cancer Surv; 1994; 19-20():323-41. PubMed ID: 7534631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.